US Broker Ratings

Pharvaris N.V. (PHVS) Stock Analysis: Potential 57.86% Upside Amid Biotech Innovations

Pharvaris N.V. (PHVS), a biopharmaceutical company rooted in Switzerland’s burgeoning biotech sector, is drawing attention from investors due to its promising pipeline of therapies targeting rare diseases, particularly those linked..

Avanos Medical, Inc. (AVNS) Stock Analysis: Exploring Growth Potential in the Medical Devices Sector

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector, has garnered attention for its innovative medical device solutions, particularly in the fields of digestive health and pain..

Syndax Pharmaceuticals (SNDX): Analyst Ratings Suggest a 92% Upside Potential

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is a dynamic player in the biotechnology sector, with a focus on developing innovative cancer therapies. As a commercial-stage biopharmaceutical company, Syndax has been capturing..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a Potential 161% Upside

Definitive Healthcare Corp. (NASDAQ: DH) is capturing investor attention with its potential for a significant upswing. Known for its innovative SaaS healthcare commercial intelligence platform, the company is strategically positioned..

Sana Biotechnology (SANA) Investor Outlook: A 144.90% Upside Potential in Innovative Cell Therapy

Sana Biotechnology, Inc. (NASDAQ: SANA), a dynamic player in the biotechnology sector, is drawing significant attention from investors with its innovative approach to using engineered cells as medicines. Based in..

Castle Biosciences, Inc. (CSTL) Stock Analysis: A Promising 145.58% Upside Potential

Castle Biosciences, Inc. (NASDAQ: CSTL) stands out in the healthcare sector, specifically within the diagnostics and research industry, as a company with a promising trajectory despite recent market challenges. Headquartered..

Praxis Precision Medicines, Inc (PRAX): Investor Outlook on a Biotechnology Challenger with 90% Upside Potential

Praxis Precision Medicines, Inc. (NASDAQ: PRAX) stands out as a significant player in the biotechnology sector, focusing on developing innovative therapies for central nervous system (CNS) disorders. With a robust..

Altimmune, Inc. (ALT) Stock Analysis: Unpacking a Potential 497% Upside in the Biotech Sector

Altimmune, Inc. (NASDAQ: ALT), a promising player in the biotechnology sector, has caught the attention of investors with a striking potential upside of 497.04%. Based in Gaithersburg, Maryland, Altimmune is..

Zenas BioPharma, Inc. (ZBIO): Unlocking a Potential 117.96% Upside in the Biotech Sector

Zenas BioPharma, Inc. (ZBIO), a clinical-stage biotechnology company, has captured the attention of investors with its transformative approach to immunology-based therapies. Headquartered in Waltham, Massachusetts, Zenas BioPharma is focused on..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Promising 55.74% Upside Potential in Precision Medicine

Tyra Biosciences, Inc. (NASDAQ: TYRA), a burgeoning name in the biotechnology sector, is making significant strides in the development of precision medicines, primarily targeting fibroblast growth factor receptor (FGFR) biology...

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Biotech with 37.54% Upside Potential

Stoke Therapeutics, Inc. (NASDAQ: STOK) stands prominently in the biotech sector, drawing significant attention from investors with its innovative approach to addressing severe genetic diseases. Specializing in antisense oligonucleotides (ASOs)..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating the Healthcare Sector with Modest Growth Potential

Enhabit, Inc. (EHAB), a key player in the healthcare sector, focuses on providing home health and hospice services across the United States. With a market capitalization of $705.38 million, Enhabit..

Weave Communications, Inc. (WEAV) Stock Analysis: A 44.63% Upside Potential in Healthcare Tech

Weave Communications, Inc. (NASDAQ: WEAV) is making waves in the healthcare technology sector with its robust AI-powered communication platform tailored for small and medium-sized healthcare businesses. As the company continues..

Nuvation Bio Inc. (NUVB) Investor Outlook: Exploring the 156% Potential Upside in Cancer Drug Innovation

Nuvation Bio Inc. (NASDAQ: NUVB) is capturing attention in the biotechnology sector with a notable potential upside of 156.41%, as indicated by its average target price of $12.33. This promising..

Community Health Systems, Inc. (CYH) Investor Outlook: Assessing the 14.29% Potential Upside

Community Health Systems, Inc. (NYSE: CYH), a key player in the healthcare sector, operates primarily in the medical care facilities industry. With a market capitalization of $408.66 million, the company..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech with 59.82% Potential Upside

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is capturing the attention of investors with its promising potential in the biotechnology sector. As a clinical-stage biopharmaceutical company, Trevi Therapeutics is pioneering innovative treatments..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring a Potential 37% Upside with Strong Buy Ratings

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector specializing in the development of pain management medications, is currently capturing the attention of investors with its promising..

Niagen Bioscience, Inc. (NAGE) Stock Analysis: Exploring a 210% Potential Upside Amidst Biotech Innovations

For investors seeking opportunities in the biotechnology sector, Niagen Bioscience, Inc. (NASDAQ: NAGE) presents an intriguing proposition. With its focus on healthy aging products and a notable potential upside, NAGE..

Replimune Group, Inc. (REPL) Stock Analysis: Navigating the Biotech Landscape with a 4.79% Potential Upside

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative oncolytic immunotherapy product candidates. As the company continues its journey to..

Maravai LifeSciences Holdings (MRVI) Investor Outlook: Navigating Biotechnology Prospects with a 16.75% Upside

Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands as a notable player in the healthcare sector, specifically within the biotechnology industry. Headquartered in San Diego, California, Maravai provides essential products and..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds